BioSpace News Archive

Wilmington, Delaware, United States: According to Transparency Market Research’s latest market report on the trocars market for the historical period of 2017–2018 and forecast period of 2019–2027, rise in the demand for minimally-invasive surgeries is anticipated to drive the global trocars market.

Microtomes are instruments that are used for making extremely thin sections of a specimen for applications in pathology or histology.

SleepScore Labs , the company behind the science of sleep improvement, will present fourteen new findings this week at SLEEP 2022 in Charlotte, North Carolina, the annual meeting of the Associated Professional Sleep Societies, LLC (APSS).

Stella, the leader in Stellate Ganglion Block treatment for emotional trauma and mental health management, and RTHM, a Long COVID clinic with expert clinicians, a research arm, and a patented treatment and diagnosis algorithm, have partnered to provide RTHM’s Long COVID patients with access to Stella’s Stellate Ganglion Block treatment.

S2 Genomics, a manufacturer of automated tissue sample preparation systems, announced at the Advances in Genome Biology and Technology 2022 general meeting the launch of the NIC+ Small Sample Cartridge for nuclei isolations from solid tissue.

United Therapeutics Corporation, a public benefit corporation, announced that in partnership with 3D Systems Corporation it has produced the world’s most complex 3D-printed object – a human lung scaffold – and demonstrated it at the LIFE ITSELF Conference that occurred May 31 to June 3, 2022 in San Diego.

Amphastar Pharmaceuticals, Inc. announced that Bill Peters, Executive V.P. and CFO, and Dan Dischner, V.P of Corporate Communications, will be presenting at the Jefferies Healthcare Conference on June 8, 2022 at 8:00 am Eastern Standard Time.

Wilmington, Delaware, United States: The global hepatorenal syndrome treatment market was valued at ~US$ 11 Bn in 2018 and is projected to reach a value of ~US$ 16.7 Bn by 2027, expanding at a CAGR of ~5% from 2019 to 2027.

The global cardiometabolic disease market is estimated to witness a stupendous growth rate in the coming years.

Yellow fever is essentially a mosquito-borne disease, which is more prevalent in African countries as well as in Central and South American region.